| Metric | Q3'25 | Q4'25 | Change |
|---|---|---|---|
| Net Sales | $3.1B (+7% YoY) | $1.7B (flat YoY) | Quarterly comp but full year 2% organic growth delivered |
| Operating EBITDA | $840M (+6% YoY) | $409M (+4% YoY) | +100 bps margin expansion to 24.2% |
| Adjusted EPS | $1.09 (flat YoY) | $0.46 (+18% YoY) | Strong acceleration driven by mix and productivity |
| Healthcare & Water Organic | High single-digit Q3 | 3% Q4 (5% adj for timing) | Maintained mid-single digit momentum |
| Diversified Industrial Organic | Low single-digit Q3 | -4% Q4 (-2% adj for timing) | Shelter drag continues but aerospace strength building |
| Diversified Industrial Margin | 25.9% Q3 | 22.6% Q4 (+110 bps YoY) | Dramatic margin expansion despite volume decline |
| Free Cash Flow Conversion | 126% Q3 | >90% guided 2026 | Strong sustained conversion expected |
| Organic Growth Guidance | 2% full year 2025 | ~3% full year 2026 | 50 bps acceleration guided |
| Vitality Index | ~30% mentioned at Investor Day | 30% maintained with $2B new product sales | 145 bps margin premium disclosed |
| Shelter Business | Down mid-single digits 2025 | Flat expected 2026 | 600+ bps improvement trajectory |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.